Skip to main content
Have a personal or library account? Click to login
Determination of Pamidronate in Bisphosphonate-Enriched Bone Cement by Ion-Pair Hplc and Capillary Electrophoresis Cover

Determination of Pamidronate in Bisphosphonate-Enriched Bone Cement by Ion-Pair Hplc and Capillary Electrophoresis

Journal of Veterinary Research
Volume 57 (2013): Issue 2 (June 2013)
By: ,  ,  ,  ,  ,   and    
Open Access
|Jun 2013
References

References

  1. 1. Abu-Amer Y., Darwech I.: Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther 2007,(Suppl 1), S6.
    Open DOISearch in Google Scholar
  2. 2. Åstrand J., Aspenberg P.: Reduction of instabilityinduced bone resorption using bisphosphonates. High doses are needed in rats. Acta Orthop Scand 2002,, 24-30.
    Open DOISearch in Google Scholar
  3. 3. Bexheti D., Anderson E.I., Hutt A.J., Brown M.A.: Evaluation of multidimensional capillary electrophoretic methodologies for determination of amino bisphosphonate pharmaceuticals. J Chromatograph A 2006,, 137-14.
    Open DOISearch in Google Scholar
  4. 4. Bock O., Börst H., Beller G., Armbrecht G., Degner C., Martus P., Roth H.J., Felsenberg D.: Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived fromμCT. Bone 2012,, 317-24.
    Open DOISearch in Google Scholar
  5. 5. Daley-Yates P., Gifford L., Hoggarth C.: Assay of 1- hydroxy-3-aminopropylidene-1,1-bisphosphonate and related bisphosphonates in human urine and plasma by high-performance ion chromatography. J Chromatogr B: Biomed Sci Appl 1989,, 329-338.
    Open DOISearch in Google Scholar
  6. 6. Fleisch H.: Bisphosphonates: mechanisms of action. Endcrinol Rev 1998,, 80-102.
    Open DOISearch in Google Scholar
  7. 7. Frith J.C., Monkkonen J., Blackburn G.M., Russell R.G., Rogers M.J.: Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5’-(β, γ-dichloromethylene) triphosphate, by mammalian cells. J Bone Miner Res 1997,, 1358-1367.
    Open DOISearch in Google Scholar
  8. 8. Gao Y., Zou S., Liu X., Bao Ch., Jing H.: The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials 2009,, 1790-1796.
    Open DOISearch in Google Scholar
  9. 9. Geoffroy V., Paschalis E.P., Libouban H., Blouin S., Ostertag A., Chappard D., Cros M., Phipps R., de Vernejoul M.C.: Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures. Calcif Tissue Int 2011,, 464-475.
    Open DOISearch in Google Scholar
  10. 10. Goldring S.R., Gravallese E.M.: Bisphosphonates: environmental protection for the joint? Arthritis Rheum 2004,, 2044-2047.
    Open DOISearch in Google Scholar
  11. 11. Goodship A.E., Blunn G.W., Green J., Coathup M.J.: Prevention of strain-related osteopenia in aseptic loosening of hip prostheses using perioperative bisphosphonate. J Orthop Res 2008,, 693-703.
    Open DOISearch in Google Scholar
  12. 12. Huikko K., Kostiainen R.: Development and validation of a capillary zone electrophoresis method for the determination of bisphosphonate and phosphonate impurities in clodronate. J Chromatogr A 2000,, 411-420.
    Open DOISearch in Google Scholar
  13. 13. Jakobsen T., Bass J., Bechtold J.E., Elmengaard B., Soballe K.: Soaking morselized allograft bone in bisphosphonate can impair implant fixation. Clin Orthop 2007,, 195-201.
    Open DOISearch in Google Scholar
  14. 14. Jia H.J., Li W., Zhao K.: Determination of risedronate in rat plasma samples by ion-pair high-performance liquid chromatography with UV detector. Anal Chim Acta 2006,, 171-175.
    Open DOISearch in Google Scholar
  15. 15. Kwong E., Chiu A.M.Y., McClintock S.A., Cotton M.L.: HPLC analysis of an amino bisphosphonate in pharmaceutical formulations using post-column derivatization and fluorescence detection. J Chromatogr Sci 1990,, 563-566.
    Open DOISearch in Google Scholar
  16. 16. Lewis G., Janna S.: Aldendronate in bone cement. Clin Orthop Rel Res 2006,, 233-238.
    Open DOISearch in Google Scholar
  17. 17. Makkonen N., Hirvonen M-R., Teräväinen T., Savolainen K., Mönkönen J.: Different effects of three bisphosphonates on nitric oxide production by Raw 264 macrophage-like cells. J Pharm Exp Ther 1996,, 1097-1102.
    Search in Google Scholar
  18. 18. Marx R.E.: Pamidronate (Aredia) and zoledronate (Zometa) induced a vascular necrosis of the jaw: a growing epidemic. J Oral Maxillofac Surg 2003,1115-1117.
    Open DOISearch in Google Scholar
  19. 19. Matuszewski Ł., Matuszewska A., Mazurkiewicz T., Rogalski J., Cho N.S., Ohga S.: Determination of bisphosphonates by ion-pair HPLC. J Fac Agr Kyushu Univ 2011,213-216.
    Open DOISearch in Google Scholar
  20. 20. Matuszewski Ł, Turżańska K, Matuszewska A, Jabłoński M, Polkowska I, Mazurkiewicz T.: Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using microcomputed tomography. International Orthopaedics. http://www.springer.com/alert/urltracking.do?id=Lfb8d2bMbe6f65Saad8ca1. Accessed 24 February 2013.
    Open DOISearch in Google Scholar
  21. 21. Mazurkiewicz T., Matuszewski Ł., Matuszewska A., Jaszek M.: Implanted bisphosphonates in bone cement affect bone markers in rat serum. International Orthopaedics. http://link.springer.com/article/10.1007/s00264-013-1816-6. Accessed 26 January 2013.
    Open DOISearch in Google Scholar
  22. 22. Migliorati C.A.: Bisphosphonates and oral cavity bone necrosis. J Clin Oncol 2003,, 4253-4254.
    Open DOISearch in Google Scholar
  23. 23. Morris C.D., Einhorn T.A.: Bisphosphonates in orthopedic surgery. J. Bone Joint Surg 2005,, 1609-1618.
    Open DOISearch in Google Scholar
  24. 24. Perjesi P., Kim T., Zharikova A.D., Li X., Ramesh T., Ramasubbu J., Prokai L.: Determination of clodronate content in liposomal formulation by capillary zone electrophoresis. J Pharma Biomed Anal 2003,, 929-935.
    Open DOISearch in Google Scholar
  25. 25. Peter B., Gauthier O., Laib S., Bujoli B., Guicheux J., Janvier P.: Local delivery of bisphosphonate from coated orthopedic implants increases implant mechanical stability in osteoporotic rats. J Biomed Mater Res A 2006,133-143.
    Open DOISearch in Google Scholar
  26. 26. Prieto-Alhambra D., Javaid M., Judge A., Murray D., Carr A., Cooper C., Arden N.: Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 2011. http://dx.doi.org/10.1136/bmj.d722.
    Search in Google Scholar
  27. 27. Rodriquez J.A.B., Desimone M.F., Iglesias S.L., Giorgieri S.A., Diaz L.E.: Validation of a capillary electrophoresis method for the analysis of ibandronate related impurities. J Pharm Biomed Anal 2007,305-308.
    Open DOISearch in Google Scholar
  28. 28. Russell R.G.G., Rogers M.J.: Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999,97-106.
    Open DOISearch in Google Scholar
  29. 29. Schindeler A., Birke O., Yu N.Y., Morse A., Ruys A., Baldock P.A., Little D.G.: Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate. J Bone Joint Surg Br 2011,, 1134-1139.
    Open DOISearch in Google Scholar
  30. 30. Sirén H., Määttänen A., Riekkola M.L.: Determination of small anions by capillary electrophoresis using indirect UV detection with sulphonated nitrosonaphtol dyes. J Chromatogr A 1997,, 293-301.
    Open DOISearch in Google Scholar
  31. 31. Sparidans R.W., Hartigh J.: Chromatographic analysis of bisphosphonates. Pharm World Sci 1999,, 1-10.
    Open DOISearch in Google Scholar
  32. 32. Tomlin J.L., Sturgeon C., Pead M.J., Muir P.: Use of bisphosphonate drug aldendronate for palliative management of osteosarcoma in two dogs. Vet Rec 2000,, 129-132.
    Open DOISearch in Google Scholar
  33. 33. Wilkinson J.M., Little D.G.: Bisphosphonates in orthopedic applications. Bone 2011,, 95-102.
    Open DOISearch in Google Scholar
  34. 34. Viereck V., Emons G., Lauck V., Frosch K.H., Blaschke S., Grundker C., Hofbauer L.: Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 2002,, 680-668.
    Open DOISearch in Google Scholar
  35. 35. Xie Z.X., Jiang Y., Zhang D.Q.: Simple analysis of four bisphosphonates simultaneously by reverse phase liquid chromatography using n-amylamine as volatile ion- pairing agent. J Chromatogr 2006,, 173-178.
    Open DOISearch in Google Scholar
  36. 36. Xuenong Z., Qingyun X., Haishengen L., Bunger M., Lind M., Bunger C.: Effect of alendronate on bone in growth into porous tantalum and carbon fiber interbody devices. Acta Orthop Scand 2003,, 596-603.
    Open DOISearch in Google Scholar
  37. 37. Zacharis C.K., Tzanavaras P.D.: Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: A review of analytical methods. J Pharma Biomed Anal 2008,, 483-496.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/bvip-2013-0045 | Journal eISSN: 2450-8608 (formerly 2300-3235)
Journal RSS Feed
Language: English
Page range: 257 - 262
Published on: Jun 21, 2013
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Keywords:
rats,
bisphosphonates,
bone cement,
ion-pair HPLC,
capillary electrophoresis
Related subjects:
Life sciences,
Molecular biology,
Microbiology and virology,
Life sciences, other,
Medicine,
Veterinary medicine

© 2013 Łukasz Matuszewski, Anna Matuszewska, Tomasz Mazurkiewicz, Izabela Polkowska, Magdalena Jaszek, Marcin Grąz, Jacek Gągała, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons License.

Volume 57 (2013): Issue 2 (June 2013)
Previous article
Next article